Cargando…

Significance of blood glucose variability in the early phase for predicting survival in acutely ill patients with glucose intolerance

Detalles Bibliográficos
Autores principales:	Hoshino, M, Haraguchi, Y, Mizushima, I, Sakai, M, Kajiwara, S, Takagi, M
Formato:	Texto
Lenguaje:	English
Publicado:	BioMed Central 2010
Materias:	Poster Presentation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2934033/ http://dx.doi.org/10.1186/cc8806

Ejemplares similares

Significance of the suppression of blood glucose variability in acutely ill severe patients with glucose intolerance evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2008)

High blood glucose variability in acute phase is one of the most important risk factors relating to the outcome in acutely ill severe patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2009)

Evaluation of glucose intolerance in acutely ill severe patients by means of an artificial pancreas
por: Hoshino, M, et al.
Publicado: (2004)

Investigation of the blood glucose target for mortality reduction by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2011)

Relationship between blood glucose level and outcome in acutely ill severe patients with glucose intolerance evaluated by means of a bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2006)

Investigation of insulin clearance in severely acutely ill patients with glucose intolerance evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2007)

Blood glucose target in acute phase suggested by the analysis of the relationship between blood glucose profile and the severity of the diseases
por: Hoshino, M, et al.
Publicado: (2014)

Influence of blood glucose-related factors to glucose tolerance in acutely ill severe patients evaluated by means of bedside-type artificial pancreas
por: Hoshino, M, et al.
Publicado: (2005)

Variable and maximum blood glucose levels during the first week after ICU admission are related to the severity of the patients
por: Hoshino, M, et al.
Publicado: (2012)

Investigation of insulin clearance in septic patients with glucose intolerance: analysis under strict blood glucose control by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2001)

Influence of insulin clearance to glucose tolerance in acutely ill severe patients: analysis with glucose clamp method by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2003)

Investigation of the factors which influence insulin sensitivity in septic patients with glucose intolerance: analysis with glucose clamp method by means of artificial pancreas
por: Hoshino, M, et al.
Publicado: (2002)

Impact of real-time continuous glucose monitoring on glucose variability in critically ill patients
por: Brunner, R, et al.
Publicado: (2010)

Blood glucose variability, measured as mean absolute glucose, strongly depends on the frequency of blood glucose level measurements
por: Harmsen, RE, et al.
Publicado: (2011)

Glucose variability and ICU outcome
por: Todi, S, et al.
Publicado: (2011)

Comparison of glucose variability measures
por: Bhattacharyya, M, et al.
Publicado: (2011)

tPA-PAl (tissue plasminogen activator—plasminogen activator inhibitor-1 complex) can be a predictive marker of multiple organ dysfunction syndrome in seriously ill acute patients with glucose intolerance — analysis under strict blood glucose control by artificial pancreas
por: Hoshino, M, et al.
Publicado: (1999)

Nasogastric feeding intolerance in the critically ill
por: OConnor, S, et al.
Publicado: (2011)

Hypercoagulability indicated by elevated blood TFPI (tissue factor pathway inhibitor) levels is closely related to severity of septic patients with glucose intolerance
por: Hoshino, M, et al.
Publicado: (2000)

Factors influencing accuracy of blood glucose measurements in critically ill patients
por: Peng, J, et al.
Publicado: (2008)

Randomized controlled study for the evaluation of automated blood glucose control in critically ill patients
por: Plank, J, et al.
Publicado: (2005)

Erythromycin or metoclopramide for feed intolerance in the critically ill
por: Nguyen, N, et al.
Publicado: (2006)

Expression of glucose transporters in critical illness
por: Langouche, L, et al.
Publicado: (2006)

Evaluation of a noninvasive blood glucose monitoring device for critically ill patients
por: Kononenko, A, et al.
Publicado: (2006)

Evaluation of a noninvasive blood glucose monitoring device for critically ill patients
por: Amir, O, et al.
Publicado: (2008)

Intensive insulin therapy in critically ill children: impact on blood glucose dynamics and its relation with mortality
por: Van Tornout, M, et al.
Publicado: (2013)

Muscular glucose assessed by microdialysis and blood glucose can predict mortality in septic shock
por: Massoudi, A, et al.
Publicado: (2013)

Protection of mitochondria by intensive insulin therapy in critical illness: blood glucose control or insulin?
por: Vanhorebeek, I, et al.
Publicado: (2006)

Accuracy of glucose measurements in critically ill patients
por: Claverie, V, et al.
Publicado: (2011)

Frequency, determinants and impact of feed intolerance amongst the critically ill
por: Gungabissoon, U, et al.
Publicado: (2012)

Fibroblast growth factor 21 response to critical illness: effect of blood glucose control and relation with mitochondrial dysfunction, the integrated stress response and survival
por: Thiessen, S, et al.
Publicado: (2015)

Time-course evaluation of blood glucose changes in response to insulin delivery in critically ill patients
por: Bass, F, et al.
Publicado: (2014)

Strict blood glucose control with insulin improves hepatic mitochondrial ultrastructure and function in critical illness
por: Vanhorebeek, I, et al.
Publicado: (2004)

Personalised glucose therapy: glucose targets in critically ill patients with pre-existing poorly controlled type 2 diabetes
por: Kar, P, et al.
Publicado: (2015)

Performance of an automated blood glucose monitor in the OR/ICU
por: Higgins, M, et al.
Publicado: (2010)

Serum glucose variability and brain-serum glucose ratio predict metabolic distress and mortality after severe brain injury
por: Kurtz, P, et al.
Publicado: (2009)

Medical problems: review from the major nuclear incidents
por: Haraguchi, Y, et al.
Publicado: (2013)

Prolonged vasopressors therapy is associated with glucose variability after cardiac surgery
por: Svetikienė, M, et al.
Publicado: (2015)

Glucose absorption following gastric and small intestinal nutrient administration in the critically ill
por: Chapman, M, et al.
Publicado: (2011)

Intensive care and disaster medicine: the role of a compendium
por: Haraguchi, Y, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_6tantv0sgm8btdner80mq55mmj